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Abstract
Exploratory analysis of high-dimensional biological sequencing data has
received much attention for its ability to allow the simultaneous screening
of numerous biological characteristics. While there has been an increase in
the dimensionality of such data sets in studies of environmental exposure
and biomarkers, two important questions have received less interest than de-
served: (1) how can independent estimates of associations be derived in the
context of many competing causes while avoiding model misspecification,
and (2) how can accurate small-sample inference be obtained when data-
adaptive techniques are employed in such contexts. The central focus of this
paper is on variable importance analysis in high-dimensional biological data
sets with modest sample sizes, using semiparametric statistical models. We
present a method that is robust in small samples, but does not rely on arbi-
trary parametric assumptions, in the context of studies of gene expression
and environmental exposures. Such analyses are faced with not only issues
of multiple testing, but also the problem of teasing out the associations of bi-
ological expression measures with exposure, among confounds such as age,
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race, and smoking. Specifically, we propose the use of targeted minimum
loss-based estimation (TMLE), along with a generalization of the moderated
t-statistic of Smyth, relying on the influence curve representation of a sta-
tistical target parameter to obtain estimates of variable importance measures
(VIM) of biomarkers. The result is a data-adaptive approach that can esti-
mate individual associations in high-dimensional data, even with relatively
small sample sizes.
1 Introduction
This paper proposes a straightforward extension of an empirical Bayes inferential
method, the moderated t-statistic ([9]), as implemented in the “limma” software
package, to general asymptotically linear estimators (e.g., [11], [14]). By way
of this extension, estimators of more complex target parameters, in the context
of many comparisons, can benefit from the inferential robustness that the moder-
ated t-statistic provides. As a motivating example, consider a previous study of
mRNA expression and occupational exposure to benzene ([5]): The data consisted
of around 22,000 genes (measured via the Illumina Human Ref-8 BeadChips plat-
form) on 125 subjects in factories in China. The main variable of interest was
occupational benzene exposure (measured in various ways), though information
on several confounding factors was also gathered (e.g., gender, smoking status).
Taking benzene exposure to be binary, the quantity of interest may be framed as
the adjusted association of each of the over 20,000 expression values with ben-
zene exposure. One could easily use the moderated t-statistic approach by fitting
a parametric linear model with, say, benzene as outcome and both exposure and
confounders as predictors, and performing a multiple testing correction on the es-
timated coefficients associated with benzene. However, it is generally desirable
to employ a procedure that is more assumption-free, specifically one that esti-
mates a nonparametric estimand, where fitting of the model could be done via
automated, data-adaptive techniques (i.e., machine learning). We show that utiliz-
ing the moderated t-statistic in situations such as this is possible if asymptotically
linear estimators are used, that is, where the difference between the values taken
by the estimator and the true parameter can be approximated by an i.i.d. sum
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of random variables (i.e., the influence curve). Many complex parameters have
asymptotically linear estimators, and so with minor modifications, the moderated
t-statistic can be applied to a wide variety of settings. This is particularly valuable
in smaller samples, as sampling distribution estimates for these complex estima-
tors can be unstable, yielding false positives, and the empirical Bayes approach of
the moderated t-statistic can ameliorate their performance by borrowing estimates
of the sampling variability across the variables of interests (in our case, gene ex-
pressions). In this way, one can use data-adaptive methods to avoid the bias of
arbitrary parametric assumptions, which are common in bioinformatical appli-
cations, while still providing a degree of robustness for this potentially unstable
estimators.
In the following sections, we first present in detail a data-adaptive, machine
learning-based estimator of a well-known estimand for deriving adjusted associa-
tions. We then show how the machinery of the “limma” approach may be used to
derive an empirical Bayes estimate of the standard error of this estimator — and,
generally, for any asymptotically linear estimator. Finally, we apply the resulting
procedure to the genomic example (of occupational benzene exposure) previously
described.
2 Methodology
2.1 Data, Model and Target Parameter
Others have proposed using estimators developed for lower dimensional “causal
inference” problems to derive nonparametric association estimators in context of
high-dimensional biomarker discovery studies (e.g., [12]). In this case, the goals
of analysis of more typical parametric approaches are similar, but the approach is
based on nonparametric estimands and can be estimated with data-adaptive (ma-
chine learning) methods. Such data structures typically consist of large matrices
of biological expression values as well as tables of phenotypic information on each
subject. In particular, in later sections, we will illustrate the use of our technique
on data generated by the Illumina Human Ref-8 BeadChips platform, from a study
which included expression measures on about 22,000 genes as well as phenotypic
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information, on a sample of 125 subjects. The aim of the analysis is to evaluate
the association of an environmental exposure (to benzene) on the expression mea-
sures of the roughly 22,000 probes (biomarkers) simultaneously, controlling for
the several aforementioned confouders.
In our analysis, we considered three potential confounding factors on the rela-
tionship of exposure and expression: age, sex, and smoking status. This problem
setup is easily generalizeable to situations with greater numbers of potential expo-
sure biomarkers and confounders. For instance, one aim of analyzing data sets of
the type described can be to rank the importance of a set of candidate biomarkers
based on their independent associations with a treatment variable (exposure, in
the case described in 2.1). In order to build a ranking of biomarkers, we start by
defining a variable importance measure (VIM) [14].
Let O = (W,A,Y ) represent a random variable defined on the observed data,
whereW are the confounders, A the exposure of interest, andY =(Yb,b= 1, . . . ,B)
a vector of potential biomarkers. Note that we observe n i.i.d. copies of the ran-
dom variable O, such that Oi = (O1, . . . ,On). Further, let O ∼ P0 ∈ M, so that
P0 is the unknown probability distribution of the full data. For the specific data
set described in Section 2.1, W = (W1,W2,W3,W4,W5), where age (W1) is a con-
tinuous measure, gender (W2) is binary, smoking status (W3) is binary, BMI (W4)
is a continuous measure, and alcohol consumption (W5) is binary; A is a binary
exposure; and Yb are miRNA expression measures.
To define the parameter of interest, generally, let Ψ(P0) be the target parame-
ter based on a function Ψ that maps the probability distribution P0 into the target
feature of interest. Thus, the parameter Ψ(P0) is a function of the unknown prob-
ability distribution P0, defined on the full data. Let Pn represent the empirical
distribution of the observed data O1,O2, . . . ,On. As noted above, we will focus on
cases when the Oi are i.i.d., but one can easily generalize the following when the
data are clustered (e.g., have repeated samples from the same biological unit). We
are interested in substitution estimators of the form Ψ(P∗n ), for some estimate P∗n
of the true distribution P0 — that is, we apply the same mapping as Ψ, but to the
empirical distribution, Pn to derive our estimate (e.g, Ψ could be the expectation
operator). In using this general definition, we expand the parameters of inter-
est beyond coefficients in a misspecified parametric statistical model, by defining
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a parameter as a feature of the true probability distribution P0 of the full data.
Specifically, we propose here what is referred to as a targeted variable importance
measure [1]:
Ψb ≡Ψb(P0) = EW,0[E0(Yb | A= 1,W )−E0(Yb | A= 0,W )]. (1)
The parameter delineated in (1) above is defined with respect to a causal
model, and, in the case that causal assumptions hold, is interpreted as the dif-
ference in the mean of the measure of biomarker expression had everyone re-
ceived exposure and the same quantity had no one received exposure [6]. This
parameter is generally referred to as the “average treatment effect,” often denoted
simply as the ATE [8]. When the assumptions underlying the causal model do
not hold, the target parameter of interest still has a straightforward statistical in-
terpretation — specifically, it is the difference in means of expression for each
biomarker, averaged over strata of baseline covariates. It has been shown that, un-
der identifiability assumptions (e.g., no unmeasured confounding), this parameter
can be statistically estimated via targeted maximum likelihood estimation [14].
Such parameters are significant in that they are not defined explicitly via paramet-
ric statistical models, leaving one free to fit the requisite models data-adaptively,
minimizing assumptions wherever possible, and yet still estimating a relatively
simple parameter with rich scientific interpretation.
2.2 Estimation
As noted previously, the target parameter is defined as a feature of the unknown
probability distribution P0. While there are several general classes of estimators
available for estimating Ψ, here we focus on a substitution estimator. Examining
1, one can anticipate that a substitution estimator will rely on estimates of two
components of the data-generating process, P0: E0(Y | A= a,W ) and P0(w), or the
true regression ofY on (A,W ) and the marginal distribution ofW . Let Qb0(A,W )≡
E0(Yb | A,W ), and Qbn(A,W ) an estimate of this regression. If we use the empirical
distribution to estimate the joint marginal distribution of theW , then a substitution
estimator is:
Ψb(Pn) =
1
n
n
∑
i=1
Qbn(1,Wi)−Qbn(0,Wi). (2)
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Below, we discuss recommendations for an initial estimate of Q0 (Super Learner),
and a bias-reducing augmentation (targeted maximum likelihood estimation) with
optimal properties for minimizing the error of estimation and deriving robust in-
ference.
2.2.1 Applying the Super Learner algorithm
The first step in the two-stage TMLE procedure is to derive an initial estimate
of Qb0, referred to as Q
(b,0)
n . For instance, one could assume a parametric statis-
tical model that results in (1) being equivalent to a regression coefficient (e.g.,
Qb0(A,W ) = α
b+β bAA+β
b
WW ). To avoid the pitfalls associated with model mis-
specification, we elect to define 1 in a nonparametric statistical model, using
data-adaptive tools to estimate Qb0. Specifically, given that the true model Q
b
0 is
typically unknown, more accurate estimates may be derived by employing data-
adaptive (machine learning) algorithms in the estimation procedure.
This reliance on machine learning algorithms leads naturally to the issue of
choosing an optimal data-adaptive algorithm. To address this issue, we advocate
use of the Super Learner algorithm, which is a generalized stacking algorithm for
ensemble learning, implemented via cross-validation, which produces an estimate
that is optimally weighted to minimize the cross-validated risk. Using this proce-
dure, the predictions from a set of candidate algorithms are combined, allowing
for highly data-adaptive functional forms to be specified [13].
Though the set of candidates algorithms in the library may be arbitrary, the
theoretical underpinnings of the Super Learner algorithm offer guidance as to the
type and number of learning algorithms that ought to be considered in the fitting
routine. In the rare case that one of the candidate learning algorithms captured the
true model and, consequently, converged to the correct estimate at a parametric
rate, the Super Learner algorithms has been shown to converge to the same esti-
mate at a near-parametric rate. As true relationships are rarely captured by lone
learning algorithms, the Super Learner will, up to a first order term, do as well (in
terms of risk) as an algorithm that chooses the particular candidate learner based
on full knowledge of the true distribution (that is, an Oracle Selector), a result
that holds as long as the number of candidate algorithms is polynomial in sample
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size. The Super Learner algorithm is available as a software package [13] for the
R programming language [7].
2.2.2 Targeted minimum loss-based estimation (TMLE)
While the Super Learner estimate of Q0 is performed to minimize the cross-
validated risk based on some appropriate loss-function, Q0 is not the target of
our analysis, Ψb is. There is no guarantee that, given a set of highly data-adaptive
learning algorithms, the estimate of Ψb has a normal sampling distribution, es-
pecially in cases of small sample size. Fortunately, [14] introduced an estimator
of Q0 that not only “targets” the estimate of the regression towards the particular
parameter of interest but also “smooths” the estimator such that the sampling dis-
tribution converges reliably to a normal distribution. This “targeting” step can be
thought of as reducing bias, since the data-adaptive selection procedure of Super
Learner results in an estimate of Ψb that suffers from residual confounding. This
form of confounding can occur, for instance, if the variable selection step in the
procedure estimatingQb0 leaves out any regressors that are, in truth, confounders of
the association of A and Y . In this case, bias in estimation of Ψb(P0) is caused by
under-fitting. Thus, the resultant targeted minimum loss-based estimator is more
robust to model mis-specification than the initial substitution estimator (based on
the initial fit of Super Learner), and is also (if one has consistent estimates of all
relevant portions of P0, the semiparametrically locally efficient. For a detailed dis-
cussion of the theory of TML estimators and formal justifications of the efficiency
of the resultant estimator, the interested reader is directed to the appendix of [14].
Algorithmically, the TML estimator in our case is a simple one-dimensional
augmentation of the initial fit. Specifically, in the case of a continuous outcome,
following the initial Super Learner fit, one proceeds by fitting a simple, one-
dimensional regression:
Q(b,1)n (A,W ) = Q
(b,0)
n (A,W )+ εˆhgˆ(A,W )
where the initial fit, Q(b,0)n (A,W ) is treated as an offset, and hgˆ(A,W ) is a ”clever”
covariate:
hgˆ(A,W ) =
I(A= 1)
gˆ(1 |W ) −
I(A= 0)
gˆ(0 |W )
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where gˆ(1 |W ) is an estimate of the P(A= 1 |W ) or the propensity score [8]; εˆ is
the estimated coefficient from the regression ofY on hgˆ(A,W ) treatingQ
(b,0)
n (A,W )
(or its logit if regression is logistic) as the offset. The selection of gˆ can be made
via a process that minimizes the mean-squared error of the parameter of inter-
est [3], but for our application, a simple main-terms logistic regression is usually
used. In the final step of this procedure, the TML estimate of Ψb is derived using
the augmented estimate of Q:
Ψˆb(P∗n ) =
1
n
n
∑
i=1
[Q(b,1)n (1,Wi)−Q(b,1)n (0,Wi)], (3)
where P∗n is the estimate of the data-generating distribution based on TMLE, in
this case, based on estimates gˆ,Q(b,1)n .
2.3 Statistical Inference
2.3.1 An approach using influence curves
As shown in [14], Ψb(P∗n ) is an asymptotically linear estimator of Ψb(P0), with
influence curve IC(Oi) if it satisfies
√
n(Ψb(P∗n )−Ψb(P0)) =
1√
n
n
∑
i=1
IC(Oi)+op(1). (4)
Note from equation 4 above that the variance of Ψˆb(Pn) is well approximated by
the sample variance of the influence curve divided by the sample size. When
considering biomarkers, the plug-in influence curve (IC) for the ATE is
ICb,n(Oi) =
[
I(Ai = 1)
gn(1 |Wi) −
I(Ai = 0)
gn(0 |Wi)
]
(Yb,i−Q(b,1)n (Ai,Wi))
+Q(b,1)n (1,Wi)−Q(b,1)n (0,Wi)−Ψb(P∗n )
With the above in hand, we can derive asymptotic p-values and confidence
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intervals (CI) with a Wald-type testing approach:
p-value = 2
[
1−Φ( |Ψb(P
∗
n )|
σbn/
√
n
)
]
(5)
(1 - α) CI =Ψb(P∗n )±
Z(1−α)σbn√
n
(6)
where σbn is the sample standard deviation of ICb and Φ(·) is the CDF of the
standard normal distribution.
2.3.2 The moderated t-statistic for influence curve-based estimates
In high-dimensional settings, with small sample sizes, direct application of TMLE
to obtaining joint inference for a targeted variable importance measure can result
in unstable standard error estimates, and thus erroneous identification of biomark-
ers. This is particularly important if data-adaptive procedures are being used,
which can add to finite-sample non-robustness. To address this problem, we ap-
ply the moderated t-statistic of [10], a technique that preserves accurate asymp-
totic inference, yet, provide robust inference in finite (small) samples by drawing
on information across the many estimates of sampling variability (the σbn ) using
an empirical Bayes procedure. First developed for the analysis of data from mi-
croarray experiments, the moderated t-statistic is implemented in the immensely
popular R package “limma”, which provides a suite of tools for analyzing the dif-
ferential expression of genes using linear models, borrowing information across
all genes to provide stable and robust inference for microarray data [10]. Previ-
ously, we noted that a common way of making inference about the target param-
eter Ψb is to compute the influence curve-based values for Ψb, which can then
be used to calculate the corresponding standard errors of the influence curve of
Ψb. After obtaining these IC values, finding corresponding p-values and making
inference about Ψb for each probe follow trivially.
The procedure for using the moderated t-statistic on IC-based estimates of
Ψb, using the ”limma” R package to impose variance shrinkage with an empirical
Bayes procedure, is as follows:
• Assume repeated tests, across b, of nulls and alternative: H0 : Ψb(P0) =
0,HA :Ψb(P0) 6= 0.
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• Find influence curve-based estimates for each probe, one at a time, using
these to iteratively build a matrix of IC-based estimates of the ATE across
all subjects, for all probes.
• Since the IC-based estimates have mean zero, add in the corresponding es-
timates of Ψb(Pn) to each row (probe/biomarker). This results in each row
having an appropriate average(Ψb(Pn)) and sample variance equivalent to
that of the influence curve for that probe (ICb).
• Using the implementation readily available in the “limma” R package, de-
rive the moderated t-statistic (t˜b,b= 1, . . . ,B) to the aforementioned matrix
of IC-based estimates of the ATE, resulting in a multiple testing procedure
across the relative to the null hypotheses listed above.
• The resulting inference, based on the shrinkage estimate of the sampling
standard deviation of the influence curve (σ˜bn ) is a weighted average of σbn
and a value close to the average of all these sample standard deviation esti-
mates across the biomarkers (σbn≈ 1B∑Bb=1σbn , or σ˜bn =wtbσbn +(1−wtb)σbn,
where wtb ∈ (0,1)). See [10] for a formal presentation. Asymptotically, as
n→ ∞, wtb→ 1, and thus σ˜bn → σbn .
• Use multiple testing corrections to obtain accurate simultaneous inference
for all probes. In standard practice, we recommend the Benjamini-Hochberg
procedure for controlling the False Discovery Rate [2].
This procedure, as described above, will shrink (potentially) aberrant estimates
of variability estimates toward the center of the joint distribution, with a particu-
larly noticeable effect when the sample size is small. The practical effect is that it
tends to reduce the number of significant biomarkers, driven by (potentially) erro-
neous underestimates of variation of the parameter estimates of interest, Ψb(Pn).
The convenience of this approach is that it can handle any asymptotically linear
estimator (can be represented as in 4), which covers many if not most estimators of
parameters of interest. The “biotmle” R package, an open source implementation
of the described procedure, is publicly available [4].
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3 Data Analysis
For the gene expression data set, measured using the Illumina Human Ref-8 Bead-
Chips platform, previously described in 2.1, we applied the TMLE-based biomarker
evaluation procedure to obtain independent estimates of the association of each of
the nearly 22,000 biomarkers with benzene exposure, while controlling for po-
tential confounding based on age, sex, and smoking status. The values obtained
from applying this procedure on a biomarker-by-biomarker basis correspond to
the contributions of each potential biomarker to changes in the ATE, based on the
influence curve decomposition of the ATE parameter. While having a direct in-
terpretation in relation to the ATE, such transformed expression values hold little
bearing on statistical inference.
Using the ATE, the moderated t-statistic for the test performed is as follows:
t˜b =
√
n ·Ψ(P∗n )
σ˜bn
,
where S˜2b,n=
d0S20+db(σ
b
n )
2
d0+db
where db is the degrees of freedom for the bth biomarker,
d0 is the degrees of freedom for the remaining biomarkers, σbn is the standard de-
viation for the bth biomarker and S0 is the common standard deviation across all
biomarkers towards which empirical Bayes performs shrinkage.
In order to isolate a set of differentially upregulated or downregulated biomark-
ers, we apply the moderated t-statistic of [9] to test for group differences based on
the observed benzene exposure status. This results in a table including the mod-
erated t-statistic for each test of the ATE-transformed values between the exposed
and unexposed groups (a coefficient corresponding to exposure in the gene-wise
linear models fit via the “limma” R package), standard errors of the coefficient,
raw p-values, and the adjusted p-values based on the Benjamini-Hochberg proce-
dure for controlling the False Discovery Rate [2]. The following table presents
these results:
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Biomarker ID ATE Change p-value adjusted p-value
1 198 1.69167E+01 1.04812E-54 2.90551E-51
2 1055 8.30585E+00 1.73105E-47 1.74498E-44
3 1764 -1.83308E+00 6.00103E-55 1.90121E-51
4 2469 1.70375E+02 2.87168E-47 2.76893E-44
5 3607 -4.36856E+00 6.07654E-47 5.39038E-44
6 4195 7.19651E+00 1.38153E-52 2.78529E-49
7 6207 -3.05520E+01 1.17986E-57 5.23316E-54
8 6262 -1.30293E+01 8.96437E-49 1.10446E-45
9 7481 -2.72348E+01 1.06992E-48 1.24883E-45
10 8664 -9.94950E+01 3.25553E-47 3.00824E-44
11 10255 1.07510E+01 9.07492E-54 2.01255E-50
12 11073 -2.88118E+01 7.45674E-54 1.83742E-50
13 12898 -2.50923E+01 1.34871E-58 7.47759E-55
14 14003 -1.84590E+01 5.86475E-59 4.33542E-55
15 14472 7.39674E-01 2.61339E-52 4.82976E-49
16 16255 -3.41521E+01 1.31512E-50 2.08324E-47
17 16454 -5.35507E+00 8.58888E-48 9.52378E-45
18 16608 -3.34112E+00 1.16964E-55 4.32320E-52
19 16658 -6.27276E+00 2.21905E-51 3.78552E-48
20 17537 -1.77342E+02 2.27910E-59 2.52718E-55
21 17982 -1.09417E+02 4.52028E-63 1.00246E-58
22 18337 1.49518E+00 1.87252E-49 2.44275E-46
23 19399 -1.06334E+02 3.36332E-50 4.97256E-47
24 20294 -1.16305E+02 1.64737E-47 1.73970E-44
25 22058 -1.13907E+01 6.07700E-50 8.42310E-47
The analysis presented can be completely replicated by using the “biotmle”
R package, which provides facilities for visualizing the results. Applying this
R package, a heatmap visualizing the ATE difference induced by benzene ex-
posure, with the 125 subjects on the x-axis and the top 25 biomarkers based on
BH-corrected p-values on the y-axis, was produced and is presented below:
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Figure 1: Heatmap of the ATE estimates. Blue indicates a depression in the ATE,
while red indicates an increase in the ATE, based on exposure to the maximal level of
benzene as opposed to the minimal level.
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As expected, Limma reduced the spread of the standard deviation estimates of
the influence curve by probe (σ˜bn ) across the nearly 20,000 probes, and the corre-
sponding Wald statistics for testing the targeted parameter, in comparison of using
the original standard error, σbn . The results of our analysis indicate that the mod-
erated t-statistic applied to the ATE constitutes a powerful approach for assessing
variable importance, based on exposure, in the context of high-dimensional in-
vestigations of biomarkers. We conclude that using this adaptation of the TMLE
approach, complimented by the moderated t-statistic of the R package “limma,”
reduces the variability of standard errors and reduces the number of significant
probes, leading to mor stable and robust inference, while providing the oppor-
tunity to evaluate biomarkers in the context of statistical parameters of scientific
relevance, such as the average treatment effect focused on in the above example.
4 Discussion
The goal of the present paper is the introduction of an automated, robust method
for analyzing high-dimensional exposure and omics data with relatively modest
sample sizes. In the provided examples, the challenge was two-fold, including
both simultaneous inference for a large number of comparisons and adjustment
for potential confounders, all in the context of a large statistical model and small
numbers of biological replicates. Since the goal here is estimation within a very
large statistical model, the technique must involve data-adaptive estimation, while
still providing trustworthy statistical inference and estimators grounded in semi-
parametric efficiency theory. That is, given the parameter of interest and the nature
of the statistical model, we maintain that the choice guiding the algorithm should
not be ad hoc, but rather based on the relative efficiency of competing estimators.
We have proposed methods that draw on existing work in statistical genomics
and merge these with modern proposals for the analysis of variable importance,
ultimately yielding a procedure that data-adaptively identifies promising biomark-
ers from a large set and that can be applied to data generated from experiments
belonging to a large class of study designs.
We illustrated the method using an example miRNA data set (featuring ben-
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zene exposure) by applying, on a probe-by-probe basis, the outlined approach,
combining TMLE with the moderated t-statistic to estimate the association of
each potential biomarker with exposure. Thus, we present a flexible generaliza-
tion of the moderated t-statistic to the case of asymptotically linear paramaters,
obtaining robust small-sample inference, derived from influence curve-based esti-
mation of the parameter of interest. The results suggest that instabilities inherent
in small-sample inference can be ameliorated by combining this asymptotically
efficient estimator of the ATE (based on TMLE) with the moderated t-statistic
(implemented in “limma”; in our example, this results in the isolation of fewer
statistically significant biomarkers. Since application of the “limma” framework
has no impact on asymptotics — the adjustment to the within probe inference
becomes negligible as sample size grows — we can readily use the asymptotic
theory underlying TMLE.
This combination of existing methods offers many advantages: 1) it estimates
target parameters relevant to specific scientific questions, in the presence of many
confounders, without placing assumptions on the underlying statistical model; 2)
it uses the theoretical optimality of loss-based estimation via the Super Learner
algorithm, which optimally balances the bias-variance tradeoff in finite samples
by appropriately choosing a level of parsimony to match the information avail-
able in the sample; 3) its reliance on targeted minimum loss-based estimators
reduces residual bias and adds an appropriate degree of smoothing, making influ-
ence curve-based based inference available for the target parameters of interest;
and 4) it robustifies inference by using the moderated t-statistic to derive joint
inference with fewer false positives than would result from otherwise poor esti-
mation of the sampling variability of the estimator. The result is a theoretically
sound, data-adaptive estimation procedure, based on pre-specified, flexible learn-
ing algorithms, that guarantees robust statistical inference. While the continuing
development of new biotechnologies promises new insights into the myriad rela-
tionships between biomarkers and health, procedures like the one presented here
will surely be necessary to ameliorate the pitfalls of increasing dimensionality of
the scientific problems of interest, by providing a rigorous and generalize-able
statistical framework for accurate, robust, and conservative biomarker discovery.
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